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Abstract Hydrazide–hydrazone derivatives are present in
many bioactive molecules and display a wide variety of
biological activities, such as antibacterial, antitubercular,
antifungal, anticancer, anti-inﬂammatory, anticonvulsant,
antiviral, and antiprotozoal action. Therefore, many med-
icinal chemists synthesize various hydrazide–hydrazones
and evaluate them for biological activities. Among biolo-
gical properties of this class of compounds, antimicrobial
activity is the most frequently encountered in scientiﬁc
literature. This paper is focused on the overview of the
literature ﬁndings of the last six years (2010–2016)
covering the research on antimicrobial activity of
hydrazide–hydrazone derivatives. This review may also
serve as a useful guide for the development of new
hydrazide–hydrazones as potential antimicrobial agents.
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Abbreviations
MIC Minimal inhibitory concentration
ZOI Zone of inhibition
A. ﬂavus Aspergillus ﬂavus
A. niger Aspergillus niger
B. megaterium Bacillus megaterium
B. sphaericus Bacillus sphaericus
B. subtilis Bacillus subtilis
C. albicans Candida albicans
C. glabrata Candida glabrata
C. tropicalis Candida tropicalis
C. tenuis Candida tenuis
C. neoformans Cryptococcus neoformans
E. aerogenes Enterobacter aerogenes
E. faecalis Enterococcus faecalis
E. coli Escherichia coli
F. oxysporum Fusarium oxysporum
K. pneumoniae Klebsiella pneumoniae
L. monocytogenes Listeria monocytogenes
M. luteus Micrococcus luteus
M. tuberculosis Mycobacterium tuberculosis
P. mirabilis Proteus mirabilis
P. vulgaris Proteus vulgaris
P. aeruginosa Pseudomonas aeruginosa
P. picketti Pseudomonas picketti
S. enterica Salmonella enterica
S. typhi Salmonella typhi
S. typhimurium Salmonella typhimurium
S. aureus Staphylococcus aureus
S. epidermidis Staphylococcus epidermidis
S. pneumoniae Streptococcus pneumoniae
V. cholerae Vibrio cholerae
Introduction
Hydrazide–hydrazones constitute a class of organic com-
pounds, which attracts the attention of medicinal chemists
due to the fact that they contain azomethine group
(–NH–N=CH–) connected with carbonyl group, which is
responsible for their different pharmaceutical applications
and makes possible the synthesis of different heterocyclic
scaffolds (Rollas and Küçükgüzel 2007), like 1,3,
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4-oxadiazolines (Doğan et al. 1998), azetidin-2-ones (Kalsi
et al. 2006), coumarins (Mohareb et al. 2011), 1,3-thiazo-
lidin-4-ones (Popiołek et al. 2015, 2016a), and 1,3-ben-
zothiazin-4-ones (Popiołek et al. 2016b).
The main route to synthesize hydrazide–hydrazone
derivatives is the heating of appropriate hydrazides of car-
boxylic or heterocarboxylic acids with different aldehydes
or ketones in various organic solvents like ethanol, metha-
nol or butanol (Bala et al. 2013; Popiołek et al. 2015,
2016a; Popiołek and Biernasiuk 2016a, b). The molecular
stucture of synthesized hydrazide–hydrazone derivatives
can be easily conﬁrmed by spectral methods. In the IR
spectra, three characteristic bands are observed. The peaks
around 1550 cm−1 correspond to the presence of C=N
group. Carbonyl group (C=O) gives a characteristic band
around 1650 cm−1, whereas the NH group can be found in
the area around 3050 cm−1. In the 1H NMR spectra of
hydrazide–hydrazones, we can observe a characteristic
singlet signal in the range of δ 8–9 ppm, and the second
singlet signal around δ 10–13 ppm, which correspond to
=CH and NH groups, respectively. In the 13C NMR spectra,
the signal for =CH group usually appears around δ
145–160 ppm, whereas in the range of δ 160–170 ppm we
can observe the signal for carbonyl group (C=O) (Mohareb
et al. 2011, Popiołek and Biernasiuk 2016a, b).
In recent years, a lot of biologically important
hydrazide–hydrazone derivatives with a number of func-
tional groups have been synthesized from many different
carbonyl compounds. They were found to possess anticancer
(Kumar et al. 2012; Yadagiri et al. 2014; Machakanur et al.
2012; Nasr et al. 2014), anti-inﬂammatory (Kumar et al.
2015), anticonvulsant (Çakır et al. 2001), antiviral (Şen-
kardes et al. 2016), and antiprotozoal (Siddiqui et al. 2014)
activities. Among the biological properties of this class of
compounds, the antimicrobial activity is the most frequently
encountered one in scientiﬁc literature. Additionally, widely
used chemotherapeutic agents such as nitrofurazone
(McCalla et al. 1970), furazolidone (Chatterjee and Ghosh
1979; Ali 1983), and nitrofurantoin (McOsker and Fitzpa-
trick 1994; Munoz-Davila 2014) are known to con-
tain typical hydrazide–hydrazone moiety or hydrazide-
hydrazone moiety, in which the carbonyl group and nitro-
gen atom are included in the 1,3-oxazolidine-2-one or imi-
dazolidine-2,4-dione ring (Fig. 1).
Encouraged by the above mentioned facts, this study is
an attempt to collect the hydrazide–hydrazone derivatives,
which can be considered as potential antimicrobial agents,
reported in the literature in the years 2010–2016.
Antibacterial activity
Searching for effective and non-toxic chemotherapeutic
agents is still a very important issue due to the increase of
multi-resistant bacterial strains (Moellering 2011). The
treatment of bacterial infections is especially challenging in
patients with compromised immune systems or with other
associated diseases (Coates et al. 2002). Some of currently
used antibacterial agents are known to contain
hydrazide–hydrazone moiety (McCalla et al. 1970; Chat-
terjee and Ghosh 1979; Ali 1983; McOsker and Fitzpatrick
1994; Munoz-Davila 2014) (Fig. 1). Due to this fact, it is
reasonable to search for novel antibacterial agents among
hydrazide–hydrazone derivatives.
The in vitro screening results of newly synthesized
benzimidazole derivatives bearing hydrazone moiety
revealed that some of the compounds had signiﬁcant anti-
microbial activity (Özkay et al. 2010). Among synthesized
derivatives, compounds 1 and 2 had bactericidal effect on
the growth of Salmonella typhimurium, two times better
(compound 1: MIC = 6.25 μg/ml) or equal (compound 2:
MIC = 12.5 μg/ml) to the activity of chloramphenicol (MIC
= 12.5 μg/ml), which was used as positive control (Fig. 2).
The activity of these compounds against other Gram-
negative bacterial strains, like Escherichia coli, Proteus
vulgaris, Klebsiella pneumoniae, or Pseudomonas aerugi-
nosa, was good (MIC= 25–100 μg/ml). The activity against
Gram-positive bacteria was assessed on four strains: Lis-
teria monocytogenes, Staphylococcus aureus, Enterococcus
faecalis, and Bacillus subtilis. The best activity equal to the
Fig. 1 Chemical structures of medicines containing
hydrazide–hydrazone moiety: nitrofurazone (a), furazolidone (b) and
nitrofurantoin (c)
Fig. 2 Benzimidazoles showing interesting activity against Salmo-
nella typhimurium. R= Cl (1); Br (2)
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activity of chloramphenicol was found against E. faecalis
(MIC = 12.5 μg/ml). Against other Gram-positive bacterial
strains, the activity of compounds 1 and 2 was good to
moderate (MIC = 25–200 μg/ml) (Özkay et al. 2010).
In another research, Rasras et al. (2010) synthesized
novel hydrazide–hydrazones of cholic acid and tested them
for antibacterial activity against three Gram-negative and
three Gram-positive bacterial strains (Fig. 3). The activity of
ﬁve derivatives (3–7) against E. coli was strong (MIC =
3.91–7.81 µg/ml), but weaker than ceﬁxime, which was
used as control. Interestingly, none of the tested compounds
had any activity against P. aeruginosa and Enterobacter
aerogenes. In turn, the activity against Gram-positive bac-
terium Enterococcus faecalis for the compounds 3 and 6
(MIC = 1.96 µg/ml), 4 and 7 (MIC = 3.91 µg/ml), and 5
(MIC = 7.82 µg/ml) was almost 16, 8, and 4 times higher,
respectively, than the activity of cefaclor (MIC = 31.25 µg/
ml) and ceﬁxime (MIC = 31.25 µg/ml). The MIC values for
tested compounds against two other Gram-positive bacteria
Staphyloccocus aureus and Bacillus megaterium were also
good (MIC = 7.82–62.5 µg/ml) and comparable to che-
motherapeutics used as controls (Table 1) (Rasras et al.
2010).
Kumar et al. (2011a) evaluated novel hydrazide–
hydrazones of 4-chlorophenylsulfonyl acid for in vitro
antibacterial activity. The tested compounds (8, 9 and 10)
showed moderate to mild antibacterial activity on the basis
of the measurement of the zone of the inhibition growth
(ZOI= 10–21 mm) against two Gram-positive (Bacillus
subtillis and S. aureus) and two Gram-negative (E. coli and
Salmonella typhi) bacterial strains, when compared to
ampicillin sodium used as a control (ZOI = 20–24 mm)
(Fig. 4). The best antibacterial activity was displayed by
compound 8 (ZOI = 21 mm) against S. aureus (control ZOI
= 22 mm) and compound 10 against E. coli, whose zone of
inhibition was 21 mm, whereas for ampicillin it was 20 mm
(Table 2.) (Kumar et al. 2011a).
Among the isonicotinoyl hydrazide analogs synthesized
by Moldovan et al. (2011), compound 11 appeared
to have the strongest antibacterial activity. This
hydrazide–hydrazone derivative possesses similar to ampi-
cillin (ZOI = 16 mm) antibacterial activity (ZOI = 15 mm)
against S. aureus (Fig. 5). The activity against other Gram-
positive (Bacillus cereus) and Gram-negative bacteria (E.
coli, Salmonella thyphimurium, Proteus mirabilis, and
Salmonella enterica) was good to moderate (ZOI= 12–17
mm), when compared with chemotherapeutics used as
controls: ampicillin, ciproﬂoxacin, gentamicin, and co-
trimoxazole (Moldovan et al. 2011).
In another research, indoles containing hydrazide–
hydrazone moiety (12, 13) synthesized by Shirinzadeh et al.
(2011), showed good to moderate activity (MIC = 50–100
μg/ml) against the tested bacterial strains (Fig. 6).
Fig. 3 New derivatives of cholic acid with hydrazide–hydrazone
moiety. R= 4-ClC6H4 (3); 4-BrC6H4 (4); 4-NO2C6H4 (5); 3-ClC6H4
(6); 4-Cl-3-NO2C6H3 (7)
Fig. 4 Hydrazide–hydrazones of 4-chlorophenylsulfonyl acid with
antibacterial activity. R= 3-OCH3-C6H4 (8); 3-OH-C6H4 (9); 4-OH-3-
OCH3-C6H3 (10)
Table 1 In vitro antibacterial
screening results of novel
hydrazide-hydrazones of cholic
acid
No. of compound R MIC (μg/ml)
Gram-negative bacteria Gram-positive bacteria
E. coli S. aureus E. faecalis B. megaterium
3 4-ClC6H4 3.91 62.5 1.96 31.25
4 4-BrC6H4 3.91 62.5 3.91 7.82
5 4-NO2C6H4 7.81 31.25 7.82 31.25
6 3-ClC6H4 3.91 31.25 1.96 31.25
7 4-Cl-3-NO2C6H3 7.81 31.25 3.91 31.25
Cefaclor – na 31.25 31.25 31.25
Ceﬁxime – 1.96 31.25 31.25 na
na not active, – not applicable
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Kumar et al. (2011b) synthesized and evaluated anti-
microbial assays, as well as performed QSAR studies of
twenty 3-ethoxy-4-hydroxybenzylidene/4-nitrobenzylidene
hydrazides. Seven of the new compounds (14–20) showed
the antibacterial activity higher than that of ciproﬂoxacin
against S. aureus, B. subtilis, and E. coli (Fig. 7) (Kumar
et al. 2011b).
Two derivatives of 1,2-dihydropyrimidine (21, 22) syn-
thesized by Al-Shariﬁ and Patel (2012) showed signiﬁcant
antibacterial activity against a panel of Gram-positive bac-
teria, including B. subtilis, S. aureus and, Micrococcus
luteus, and Gram-negative bacteria, like E. coli and Pseu-
domonas picketti (Fig. 8) MIC values against these bacterial
strains were in the range of 0.08–1 µg/ml, which can be
assessed as very strong antibacterial activity. It is worth to
underline that the lowest value of MIC was presented by
compound 21 against M. luteus (MIC= 0.08 µg/ml) (Al-
Shariﬁ and Patel 2012).
Xaiver et al. (2012) synthesized novel hydrazide–
hydrazones as a result of condensation of 2,4-diaryl-3-azabi-
cyclo[3.3.1]nonan-9-ones with 4-aminobenzoic acid hydrazide
(Fig. 9). The obtained compounds were tested for in vitro
antibacterial activity against eight bacterial strains (Gram
negative bacteria: S. thypimurium, E. coli, Vibrio cholerae, S.
typhi, P. aeruginosa, and K. pneumonia, and Gram-positive
bacteria: B. subtilis and S. aureus). Among the synthesized
derivatives, it is worth to mention two compounds
23, 24, which showed good to moderate activity against all
bacterial strains (MIC= 50–200 μg/ml) (Table 3) (Xaiver et al.
2012).
In another research, Kodisundaram et al. (2013) obtained
a series of heterobicyclic methylthiadiazole hydrazones and
investigated their activity in vitro against Gram-positive and
Gram-negative bacteria. Two of the synthesized com-
pounds, 26 and 27, showed interesting activity, especially
against B. subtilis (Fig. 10). Their activity against this
bacterium (MIC = 6.25 μg/ml) was two times higher than
the activity of streptomycin (MIC= 12.5 μg/ml), which was
used as positive control. The activity of these compounds
against S. aureus was good (MIC = 25–50 μg/ml). As for
Table 2 Results of in vitro
antibacterial assays of 4-
chlorophenylsulfonyl acid
derivatives






B. subtilis S. aureus E. coli S. typhi C. albicans A. niger
8 3-OCH3-C6H4 19 21 10 10 31 20
9 3-OH-C6H4 17 20 11 14 26 21
10 4-OH-3-OCH3-C6H3 19 16 21 19 26 18
Ampicillin sodium – 24 22 20 21 – –
Clotrimazole – – – – – 30 22
– not applicable
Fig. 5 Isonicotinoyl hydrazide analog with signiﬁcant activity against
S. aureus
Fig. 6 Indoles containing
hydrazide–hydrazone moiety
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the Gram-negative bacteria, the synthesized compounds
(26, 27) showed two times better activity (MIC = 6.25 μg/
ml) than streptomycin (MIC= 12.5 μg/ml) against K.
peneumoniae, whereas against P. aeruginosa, compound 27
showed the activity equal to streptomycin (MIC = 12.5
μg/ml). The activity of the inhibition of the growth of
E. coli was also two times higher (MIC = 12.5 μg/ml)
in comparison with the control (MIC= 25 μg/ml)
(Kodisundaram et al. 2013).
Pieczonka et al. (2013) synthesized a series of new
imidazole derivatives containing hydrazide–hydrazone
moiety and evaluated them for antibacterial activity against
No of 
compound R R1 R2 R3 R4 R5
14 CH3(CH2)9CH2- H OEt OH H H 
15 CH3(CH=CH)2- H OEt OH H H 
16 CH3(CH2)9CH2- H H NO2 H H 
17 CH3(CH=CH)2- H H NO2 H H 
No of 
compound Y X1 X2 X3 X4 X5 R1 R2 R3 R4 R5
18 CH=CH H H H H H H H NO2 H H 
19 - H CH3 H H H H H NO2 H H 
20 - H H CH3 H H H H NO2 H H 
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a panel of bacterial strains. Two of synthesized compounds
(28 and 29) showed the best activity towards Staphylo-
coccus epidermidis ATCC 12228 (MIC= 4 μg/ml)
(Fig. 11). The activity of these compounds against this
bacterium was two times higher than the activity of nitro-
furantoin (MIC = 8 μg/ml). The MICs against the other
bacterial strains like, S. aureus ATCC 6538, S. aureus
ATCC 29213, and S. aureus ATCC 29213, were also low
(MIC = 11–27 μg/ml) (Pieczonka et al. 2013).
The infection caused by P. aeruginosa constitutes a
severe problem, especially for the patients with weak
immune system. In response to this, hydrazide–hydrazones
of 2,5-diﬂuorobenzoic acid were synthesized by Narisetty
et al. (2013) (Fig. 12). Among a series of new derivatives,
compound 30 showed better activity (ZOI= 21 mm) against
P. aeruginosa MTCC 424 than ampicillin (ZOI = 20 mm).
Two of other synthesized compounds (31, 32) showed also
very good activity (ZOI= 21–24 mm) against E. coli
MTCC 443, S. aureus MTCC 96 and Streptococcus pyo-
genes MTCC 442. The activity of these compounds was
higher than or comparable to the activity of ampicillin (ZOI
= 19–22 mm) (Table 4) (Narisetty et al. 2013).
Morjan et al. (2014) synthesized novel hydrazide–
hydrazones of nicotinic acid by the condensation reaction of
nicotinic acid hydrazide with various ketones (Fig. 13). The
synthesized derivatives were screened in vitro for anti-
bacterial activity against Gram-positive and Gram-negative
bacteria. The results of antimicrobial assay revealed that the
synthesized compounds had interesting antibacterial activity
against Gram-negative strains. Especially compounds 33
and 34 showed very strong activity against P. aeruginosa
(MIC = 0.22 and 0.19 μg/ml, respectively). The activity of
these compounds against K. pneumoniae was also high (33:
MIC = 3.12 μg/ml, 34: MIC = 14.00 μg/ml). The inhibitory
potency against Gram-positive bacteria Streptococcus
pneumoniae (33: MIC = 3.12 μg/ml) and against S. aureus
(34: MIC = 7.03 μg/ml) was also very signiﬁcant (Morjan
et al. 2014).
Fig. 9 Novel hydrazide–hydrazones obtained from 4-aminobenzoic
acid hydrazide. R= Br (23); Cl (24); OCH3 (25)
Fig. 10 Methylthiadiazoles with signiﬁcant activity against Bacillus
subtilis. R= F (26); Br (27)
Table 3 In vitro antibacterial screening results of 4-aminobenzoic acid hydrazide derivatives
No. of compound R MIC (μg/ml)
Gram-negative bacteria Gram-positive bacteria
S. typhimurium E. coli V. cholerae S. typhi P. aeruginosa K. pneumoniae B. subtilis S. aureus
23 Br 200 100 200 50 50 200 200 50
24 Cl 200 50 100 200 100 200 50 50
Streptomycin – 25 50 50 25 50 20 12.5 25
– not applicable
Fig. 11 New imidazole derivatives containing hydrazide–hydrazone
moiety
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Satyanarayana et al. (2014) synthesized novel
hydrazide–hydrazone derivatives of 4-(4-chlorophenyl)
cyclohexanecarboxylic acid as potential antibacterial agents
(Fig. 14). Three of the obtained compounds (35, 36 and 37)
showed good antibacterial activity (MIC = 32–64 μg/ml)
against a panel of four bacterial strains, including: S. aur-
eus, B. subtilis, E. coli, and P. aeruginosa (Table 5).
Unfortunately, the MIC values of the synthesized com-
pounds were higher than the activity of the antibiotic used
as control—ciproﬂoxacin (MIC = 5 μg/ml) (Satyanarayana
et al. 2014).
2-(2,3-Dihydrobenzofuran-5-yl)acetic acid was used
as a starting material for the synthesis of new
hydrazide–hydrazone derivatives by Kaki et al. (2014).
Among a series of synthesized derivatives, two compounds
(38 and 39) possessed interesting antibacterial activity
measured by the diameter of the zone of the inhibition
growth against two Gram-negative (E. coli and P. aerugi-
nosa) and two Gram-positive (S. aureus and S. pyogenes)
bacterial strains (Fig. 15). Compounds (38 and 39)
according to the antimicrobial activity assays, had similar
values of inhibition zone (ZOI = 19–22 mm) as ampicillin,
which was used as positive control (ZOI = 19–22 mm)
(Kaki et al. 2014).
In the research conducted by Rambabu et al. (2015), new
anacardic acid hydrazone derivatives were synthesized and
subjected to antibacterial screening. The obtained com-
pounds were tested against two Gram-negative (P. aerugi-
nosa and E. coli) and two Gram-positive (S. aureus and S.
pyogenes) bacterial strains (Fig. 16). The antibacterial
activity was assessed on the basis of the measurement of the
zone of inhibition growth. Antimicrobial assays revealed
that three of the obtained derivatives (40, 41 and 42) had
better antibacterial activity (ZOI = 20–24 mm) than the
activity of ampicillin, because their zones of inhibition were
larger than the control antibiotic (ZOI = 18–20 mm)
(Table 6) (Rambabu et al. 2015).
Tejeswara et al. (2016) synthesized a series of novel
peﬂoxacin derivatives and tested them for their in vitro
Fig. 12 New derivatives of 2,5-diﬂuorobenzoic acid with
hydrazide–hydrazone moiety. R= 4-CF3 (30); 2-CF3 (31); 2,4-diF
(32)
Table 4 Measured zones of the





R Zone of inhibition growth (mm)









30 4-CF3 24 21 22 21
31 2-CF3 23 22 24 21
32 2,4-diF 24 21 23 21
Ampicillin – 22 20 21 19
Fig. 13 Novel hydrazide–hydrazones of nicotinic acid
Fig. 14 Novel hydrazide–hydrazone derivatives of 4-(4-chlorophenyl)
cyclohexanecarboxylic acid as potential antibacterial agents. R= 2,4-
diF-C6H3 (35); 2,6-diF-C6H3 (36); 3,4-diF-C6H3 (37)
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antibacterial activity against four Gram-positive bacterial
strains and two Gram-negative bacterial strains by the agar
well diffusion method (Fig. 17). On the basis of the mea-
surement of the zone of inhibition growth, antibacterial
activity assay revealed that compounds 46 and 47 (ZOI=
24 and 26 mm, respectively) had higher antibacterial
activity compared to ciproﬂoxacin (ZOI= 23 mm) against
Bacillus sphaericus. Against other Bacillus strain, B. sub-
tilis compound 47 had a larger zone of inhibition (ZOI= 23
mm) than the reference substance (ZOI= 22 mm). Com-
pound 47 also displayed higher activity against Pseudo-
monas aeruginosa (ZOI = 25 mm) than ciproﬂoxacin (ZOI
= 21 mm) (Table 7) (Tejeswara et al. 2016).
Novel 1,2,3-triazole carbohydrazide derivatives synthe-
sized by Sreedhar et al. (2016) were tested against four
bacterial strains (Fig. 18). The measured zones of growth
inhibition for the obtained compounds were similar to those
of ciprofoxacin used as control. In the case of compound
50, its zone of inhibition against S. aureus MTCC 96 (ZOI
= 23 mm) was larger than for the reference compound (ZOI
= 22 mm). A similar situation appeared for compounds 49
and 52, their zones of inhibition (ZOI = 23 mm) were larger
than for ciproﬂoxacin (ZOI= 22 mm) against S. pyogenes
MTCC 442 (Table 8) (Sreedhar et al. 2016).
Dommati et al. (2016) obtained novel benzohydrazide
derivatives and evaluated them for in vitro antibacterial
activity (Fig. 19). The highest activity, but weaker than
control streptomicin, was shown by compounds 53 and 54
against Gram-negative bacteria: E. coli MTCC 2692 and P.
aeruginosa MTCC 2453 (ZOI= 5–13 mm), and Gram-
positive bacteria: S. aureus MTCC 902 and B. subtilis
MTCC 441 (ZOI= 18–21 mm) (Dommati et al. 2016).
Antitubercular activity
Despite the fact that tuberculosis is a curable and treatable
disease, it still remains a major cause of death and illness
(WHO 2010), which conﬁrms that seeking and developing
new antitubercular agents is needed. A survey of scientiﬁc
literature reveals that several hydrazide–hydrazones synthe-
sized during last 6 years possess interesting antitubercular
activity (Unissa et al. 2016). Additionally, it is worth to
mention that according to the most recent article published by
John et al. (2016) the 2-hydroxy-1-naphthaldehyde iso-
nicotinoyl hydrazone may act as a novel inhibitor of methio-
nine aminopeptidases from Mycobacterium tuberculosis.
Among the series of hydrazide–hydrazones synthesized
by Pavan et al. (2010), the four compounds (55, 56, 57, 58)
showed especially high activity towards M. tuberculosis
(MIC = 1.5–12.5 μg/ml) (Fig. 20) (Pavan et al. 2010).
Sriram et al. (2010) tested for antitubercular activity a
new series of 5-nitro-2-furoic acid hydrazones. New com-
pounds were obtained by the condensation reaction of 5-
Table 5 Results of in vitro
screening of novel hydrazide-
hydrazone derivatives of 4-(4-
chlorophenyl)
cyclohexanecarboxylic acid
No. of compound R MIC (μg/ml)
Gram-positive bacteria Gram-negative bacteria
S. aureus B. subtilis E. coli P. aeruginosa
35 2,4-diF-C6H3 64 64 32 32
36 2,6-diF-C6H3 64 64 32 32
37 3,4-diF-C6H3 64 64 32 32




acid derivatives with interesting
antibacterial properties
Fig. 16 New anacardic acid hydrazide derivatives. R= 3,4-diOCH3
(40); 3,4,5-triOCH3 (41); 4-SO2CH3 (42)
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nitro-2-furoic hydrazide with appropriate aldehydes and
ketones (Fig. 21). In vitro screening of the obtained com-
pounds revealed potent antitubercular activity of synthe-
sized derivatives (59–62). Especially compounds 59 and 60
showed very good activity (MIC = 4.76 and 2.65 µM,
respectively) in comparison with isoniazid (MIC = 0.72
µM) and rifampicin (MIC = 0.48 µM) (Sriram et al. 2010).
Novel thioureas containing hydrazide–hydrazone moiety
were synthesized and tested against M. tuberculosis H37Rv
(ATCC 27294) by Çıkla et al. (2010) (Fig. 22). In the
Table 6 Zone of inhibition
growth of tested anacardic acid
hydrazide derivatives




P. aeruginosa E. coli S. aureus S. pyogenes C. albicans A. niger
40 3,4-diOCH3 24 23 21 22 11 12
41 3,4,5-
triOCH3
22 22 20 21 18 23
42 4-SO2CH3 23 22 20 20 18 20
Ampicillin – 20 20 18 19 – –






Table 7 Measured zones of
inhibition growth of peﬂoxacin
derivatives
Compound Zone of inhibition growth (mm)
Gram-positive bacteria Gram-negative bacteria
S. aureus B. sphaericus B. subtilis M. luteus P. aeruginosa P. vulgaris
43 20 15 16 30 15 10
44 18 16 15 20 14 11
45 19 22 17 15 21 12
46 19 24 15 12 14 16
47 18 26 23 15 25 17
48 21 21 16 14 14 15
Ciproﬂoxacin 20 23 22 18 21 17
Fig. 17 Novel peﬂoxacin derivatives with interesting antibacterial
activity. R= 2,6-diCl (43); 4-NO2 (44); 3,4,5-triOCH3 (45); 5-Br-2-
OH (46); 2,5-diOCH3 (47); 3-OH (48)
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antitubercular assays, these compounds showed lower
activity (MIC > 6.25 μg/ml) than rifampicin used as a
reference substance (Çıkla et al. 2010).
Coelho et al.’s study (2012) evaluated the in vitro anti-
bacterial activity of 23 hydrazide–hydrazones obtained from
isonicotinic hydrazide against one M. tuberculosis
isoniazid-susceptible strain and three isoniazid-resistant M.
tuberculosis clinical isolates (Fig. 23). Interestingly, 13
derivatives showed good activity against isoniazid-resistant
strains. The best activity (better than that of isoniazid
against isoniazid-susceptible strain) was shown by com-
pound 76 (MIC = 0.98 μg/ml) (Coelho et al. 2012).
Cihan-Üstündağ and Çapan (2012) evaluated a series of
indole derivatives containing hydrazide–hydrazone scaffold
for in vitro antitubercular activity (Fig. 24). Antimycobacterial
activity was tested against M. tuberculosis H37Rv ATCC
27294 with the use of rifampicine as a control. Unfortunately
the synthesized compounds showed weaker activity (MIC>
6.25 μg/ml) than the reference substance (MIC= 0.125 μg/ml)
(Cihan-Üstündağ and Çapan 2012).
Velezheva et al. (2016) designed and synthesized a series
indole-pyridine derived hydrazide–hydrazones and evaluated
them against two M. tuberculosis strains (H37Rv and CN-40)
(Fig. 25). Based on the obtained results, hydrazide–hydrazone
derivative 85 appeared to be the most potent among examined
compounds (MIC=0.05 µg/ml) against the M. tuberculosis
H37Rv strain. Its activity was equal to that of isoniazid used
as positive control in this assay. Besides, this compound 85,
unlike isoniazid, showed signiﬁcant activity against isoniazid-
resistant M. tuberculosis CN-40 strain. Other synthesized
derivatives also displayed high antitubercular activity
(Table 9) (Velezheva et al. 2016).
Antifungal activity
Fungal infections still remain a serious problem, even
though there are many available medicines on the market
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Fig. 19 Benzohydrazide derivatives with interesting antibacterial
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(Lewis 2011). In this section, I will present several exam-
ples of hydrazide–hydrazones which possess signiﬁcant
antifungal activity.
Benzimidazole derivatives bearing hydrazone moiety
(Özkay et al. 2010) were also screened for antifungal
activity against three species of yeasts: Candida albicans,
Candida glabrata, and Candida tropicalis. The activity of
compounds 1 and 2 against these fungi was good (MIC =
50–100 μg/ml). In the case of C. tropicalis, the MICs of the
synthesized compounds (MIC = 50 μg/ml) were equal to the
MIC of ketoconazole used as control (MIC= 50 μg/ml)
(Özkay et al. 2010).
Similar research was performed by Kumar et al. (2011a).
New hydrazide–hydrazones of 4-chlorophenylsulfonyl acid
were synthesized and tested for antifungal activity on the
basis of the measurement of the zone of inhibition growth
against C. albicans and Aspergillus niger. Three of the
synthesized compounds (8, 9 and 10) showed promising
antifungal activity compared with the clotrimazole, which
was used as positive control. In the case of compound 8, the
antifungal activity (ZOI= 31 mm) was greater than the
activity of clotrimazole (ZOI= 30 mm) against C. albicans
(Kumar et al. 2011a).
The compounds synthesized by Shirinzadeh et al. (2011)
(12, 13) were subjected to antifungal assays against C.
albicans. The revealed antifungal activity was strong for
both compounds (12: MIC = 6.25 μg/ml and 13: 12.5 μg/ml,
respectively), but weaker than for ﬂuconazole (MIC = 0.78
μg/ml) (Shirinzadeh et al. 2011).
New hydrazide–hydrazone derivatives (23, 24 and 25)
(Xaiver et al. 2012) were tested against a panel of ﬁve fungi
strains including C. albicans, Fusarium oxysporum,
Aspergillus ﬂavus, A. niger, and Cryptococcus neoformans.
The measured MIC parameters against these fungi (MIC =
50–200 μg/ml) were much higher than the activity of
amphotericin B used as control substance (MIC = 25–50 μg/
ml), and the activity of these compounds can only be
assessed as good against A. niger (MIC = 50–100 μg/ml),
and as moderate against other fungi (MIC= 100–200 μg/
ml) (Table 10) (Xaiver et al. 2012).
Fig. 21 New 5-nitro-2-furoic
acid hydrazide derivatives with

















Fig. 22 Novel thioureas with activity against Mycobacterium tuber-
culosis H37Rv
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Novel heterobicyclic methylthiadiazole hydrazones syn-
thesized by Kodisundaram et al. (2013) were also tested for
antifungal activity against Aspergillus spp. and C. albicans.
The activity of compounds 26 and 27 against A. ﬂavus and
A. niger was two times higher (MIC= 12.5 μg/ml) than the
antifungal activity of ﬂuconazole (MIC = 25 μg/ml). The
MICs against C. albicans for synthesized compounds were
also two times higher (MIC = 6.25 μg/ml) than the MIC
value of ﬂuconazole (12.5 μg/ml) (Kodisundaram et al.
2013).
New anacardic acid hydrazone derivatives were sub-
jected to in vitro antifungal assays against C. albicans and
A. niger (Rambabu et al. 2015). Three of the synthesized
compounds (40, 41 and 42) showed good to moderate
antifungal activity (ZOI= 11–20 mm) based on the mea-
surement of the zone of inhibition growth in comparison
with the gryseofulvin used as control (ZOI = 24–28 mm)
(Rambabu et al. 2015).
Pyrrolidinones with hydrazone moieties synthesized by
Rutkauskas et al. (2013) showed strong (86) or good (87)
activity against Candida tenuis (86: MIC= 15.6 µg/ml and
87: 31.2 µg/ml, respectively) (Fig. 26), whereas the activity
against A. niger was lower (MIC = 500 µg/ml) (Rutkauskas
et al. 2013).
In the case of compounds 88 and 89 the antifungal
activity against C. tenuis and A. niger was much better
(Fig. 27). Compounds 88 and 89 against C. tenuis showed
the MIC values of 1.9 and 0.9 µg/ml, respectively. Com-
pound 88 displayed strong activity (MIC = 3.9 µg/ml)
against A. niger and compound 89 showed moderate
activity (MIC = 125 µg/ml) (Rutkauskas et al. 2013).
Hydrazide–hydrazones of benzoic acid synthesized by
Backes et al. (2014) showed interesting antifungal activity
against Candida spp. (Fig. 28). The activity of compounds
90–93 was very strong (MIC80= 0.5–4 µg/ml) against C.
albicans. C. glabrata was also very sensitive to the obtained
benzoic acid derivatives (MIC80= 0.5–1.0 µg/ml)
(Table 11) (Backes et al. 2014).
In the case of hydrazide–hydrazones of 4-nitrobenzoic
acid, the antifungal activity against the above mentioned
fungi strains was even better (Fig. 29). The MIC80 para-
meters for compounds 94 and 95 were 0.5 µg/ml against C.
albicans, whereas for compound 95 it was even 0.125 µg/ml
against C. glabrata. The MIC80 value for compound 94
against C. glabrata was also very low (MIC80= 0.5 µg/ml)
(Backes et al. 2014).
Additionally, compounds 96 and 97 as
hydrazide–hydrazone derivatives of 4-hydroxybenzoic acid
displayed activity only against C. glabrata (Fig. 30). The
MIC80 values against this fungus were 4 and 1 µg/ml for
compounds 96 and 97, respectively (Backes et al. 2014).
Conclusions
In conclusion, this paper gives an overview of the anti-
bacterial, antitubercular and antifungal properties of
hydrazide-hydrazone derivatives. As presented in this study
hydrazide–hydrazone moiety may be found and
Fig. 23 Hydrazide–hydrazone obtained from isonicotinic hydrazide
with in vitro activity against M. tuberculosis isoniazid-susceptible
strain
Fig. 24 Indole derivatives containing hydrazide–hydrazone scaffold
with antitubercular activity. R=H (77); CH3 (78); C2H5 (79); C3H7
(80); C6H5 (81)
Fig. 25 Novel indole derivatives with signiﬁcant antitubercular
activity. 82: R1=COOH, R2=H; 83: R1=COOC2H5, R2=H; 84:
R1= COOC2H5, R2= Cl; 85: R1= COOC2H5, R2= CH3
Table 9 MIC values of indole derivatives with hydrazide–hydrazone
moieties
No. of compound MIC (μg/ml)
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incorporated in various bioactive molecules. Thus this paper
appears to be important for further development of
hydrazide–hydrazones as potential antimicrobial agents.
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